BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33861953)

  • 1. A form of muscular dystrophy associated with pathogenic variants in JAG2.
    Coppens S; Barnard AM; Puusepp S; Pajusalu S; Õunap K; Vargas-Franco D; Bruels CC; Donkervoort S; Pais L; Chao KR; Goodrich JK; England EM; Weisburd B; Ganesh VS; Gudmundsson S; O'Donnell-Luria A; Nigul M; Ilves P; Mohassel P; Siddique T; Milone M; Nicolau S; Maroofian R; Houlden H; Hanna MG; Quinlivan R; Beiraghi Toosi M; Ghayoor Karimiani E; Costagliola S; Deconinck N; Kadhim H; Macke E; Lanpher BC; Klee EW; Łusakowska A; Kostera-Pruszczyk A; Hahn A; Schrank B; Nishino I; Ogasawara M; El Sherif R; Stojkovic T; Nelson I; Bonne G; Cohen E; Boland-Augé A; Deleuze JF; Meng Y; Töpf A; Vilain C; Pacak CA; Rivera-Zengotita ML; Bönnemann CG; Straub V; Handford PA; Draper I; Walter GA; Kang PB
    Am J Hum Genet; 2021 May; 108(5):840-856. PubMed ID: 33861953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Notch signaling pathway in skeletal muscle health and disease.
    Vargas-Franco D; Kalra R; Draper I; Pacak CA; Asakura A; Kang PB
    Muscle Nerve; 2022 Nov; 66(5):530-544. PubMed ID: 35968817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss.
    Servián-Morilla E; Takeuchi H; Lee TV; Clarimon J; Mavillard F; Area-Gómez E; Rivas E; Nieto-González JL; Rivero MC; Cabrera-Serrano M; Gómez-Sánchez L; Martínez-López JA; Estrada B; Márquez C; Morgado Y; Suárez-Calvet X; Pita G; Bigot A; Gallardo E; Fernández-Chacón R; Hirano M; Haltiwanger RS; Jafar-Nejad H; Paradas C
    EMBO Mol Med; 2016 Nov; 8(11):1289-1309. PubMed ID: 27807076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern.
    Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C
    Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
    Mandula JK; Sierra-Mondragon RA; Jimenez RV; Chang D; Mohamed E; Chang S; Vazquez-Martinez JA; Cao Y; Anadon CM; Lee SB; Das S; Rocha-Munguba L; Pham VM; Li R; Tarhini AA; Furqan M; Dalton W; Churchman M; Moran-Segura CM; Nguyen J; Perez B; Kojetin DJ; Obermayer A; Yu X; Chen A; Shaw TI; Conejo-Garcia JR; Rodriguez PC
    Immunity; 2024 May; 57(5):1124-1140.e9. PubMed ID: 38636522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of Megf10/Drpr gain-of-function on muscle development in Drosophila.
    Draper I; Saha M; Stonebreaker H; Salomon RN; Matin B; Kang PB
    FEBS Lett; 2019 Apr; 593(7):680-696. PubMed ID: 30802937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
    Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
    Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
    Choi K; Ahn YH; Gibbons DL; Tran HT; Creighton CJ; Girard L; Minna JD; Qin FX; Kurie JM
    J Biol Chem; 2009 Jun; 284(26):17766-74. PubMed ID: 19398556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assemblies of JAG1 and JAG2 determine tracheobronchial cell fate in mucosecretory lung disease.
    Reynolds SD; Hill CL; Alsudayri A; Lallier SW; Wijeratne S; Tan ZH; Chiang T; Cormet-Boyaka E
    JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35819850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of mice with a conditional null allele of the Jagged2 gene.
    Xu J; Krebs LT; Gridley T
    Genesis; 2010 Jun; 48(6):390-3. PubMed ID: 20533406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor.
    Luo B; Aster JC; Hasserjian RP; Kuo F; Sklar J
    Mol Cell Biol; 1997 Oct; 17(10):6057-67. PubMed ID: 9315665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch pathway repression by vestigial is required to promote indirect flight muscle differentiation in Drosophila melanogaster.
    Bernard F; Dutriaux A; Silber J; Lalouette A
    Dev Biol; 2006 Jul; 295(1):164-77. PubMed ID: 16643882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygous variants in GOSR2 associated with congenital muscular dystrophy: A case report.
    Henige H; Kaur S; Pappas K
    Eur J Med Genet; 2021 Apr; 64(4):104184. PubMed ID: 33639315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
    Katoh M; Katoh M
    Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-site amyloid precursor protein cleaving enzyme 1(BACE1) regulates Notch signaling by controlling the cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) proteins.
    He W; Hu J; Xia Y; Yan R
    J Biol Chem; 2014 Jul; 289(30):20630-7. PubMed ID: 24907271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity.
    Tchekneva EE; Goruganthu MUL; Uzhachenko RV; Thomas PL; Antonucci A; Chekneva I; Koenig M; Piao L; Akhter A; de Aquino MTP; Ranganathan P; Long N; Magliery T; Valujskikh A; Evans JV; Arasada RR; Massion PP; Carbone DP; Shanker A; Dikov MM
    J Immunother Cancer; 2019 Apr; 7(1):95. PubMed ID: 30940183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration.
    Lin S; Shen H; Jin B; Gu Y; Chen Z; Cao C; Hu C; Keller C; Pear WS; Wu L
    Stem Cells; 2013 Apr; 31(4):823-8. PubMed ID: 23307608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first report of two homozygous sequence variants in FKRP and SELENON genes associated with syndromic congenital muscular dystrophy in Iran: Further expansion of the clinical phenotypes.
    Mohamadian M; Naseri M; Ghandil P; Bahrami A; Momen AA
    J Gene Med; 2020 Dec; 22(12):e3265. PubMed ID: 32864802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAGGED2: a putative Notch ligand expressed in the apical ectodermal ridge and in sites of epithelial-mesenchymal interactions.
    Valsecchi C; Ghezzi C; Ballabio A; Rugarli EI
    Mech Dev; 1997 Dec; 69(1-2):203-7. PubMed ID: 9486542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.